These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 21512661

  • 1. The outcome of 131I treatment in Graves' patients pretreated or not with methimazole.
    Pirnat E, Zaletel K, Gaberšček S, Hojker S.
    Hell J Nucl Med; 2011; 14(1):25-9. PubMed ID: 21512661
    [Abstract] [Full Text] [Related]

  • 2. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC, Di Martino F, Grosso M, Monzani F, Dardano A, Caraccio N, Mariani G, Lazzeri M.
    Phys Med Biol; 2005 May 07; 50(9):2181-91. PubMed ID: 15843745
    [Abstract] [Full Text] [Related]

  • 3. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun 07; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 4. Early changes of thyroid hormone concentrations after (131)I therapy in Graves' patients pretreated or not with methimazole.
    Pirnat E, Zaletel K, Gaberscek S, Fidler V, Hojker S.
    Nuklearmedizin; 2004 Aug 07; 43(4):129-34. PubMed ID: 15316580
    [Abstract] [Full Text] [Related]

  • 5. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE, Michanek AM, Holmberg EC, Fink M.
    J Nucl Med; 1996 Feb 07; 37(2):228-32. PubMed ID: 8667049
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM, Shawkat W.
    Nucl Med Commun; 2008 Jul 07; 29(7):642-8. PubMed ID: 18528187
    [Abstract] [Full Text] [Related]

  • 10. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A.
    N Engl J Med; 1998 Jan 08; 338(2):73-8. PubMed ID: 9420337
    [Abstract] [Full Text] [Related]

  • 11. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
    Reinwein D, Benker G, Lazarus JH, Alexander WD.
    J Clin Endocrinol Metab; 1993 Jun 08; 76(6):1516-21. PubMed ID: 8501160
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA, Gross JL, Maia AL.
    J Clin Endocrinol Metab; 2001 Aug 08; 86(8):3488-93. PubMed ID: 11502768
    [Abstract] [Full Text] [Related]

  • 14. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
    Wu G, Jie Y, Situ Y.
    Zhonghua Yi Xue Za Zhi; 2001 Mar 10; 81(5):274-5. PubMed ID: 11798886
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL10 in hyperthyroid patients with Graves' disease.
    Leite AC, Pedro AB, Romaldini JH.
    Horm Metab Res; 2011 Mar 10; 43(3):194-9. PubMed ID: 21283953
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O, Schulz G, Zimny M, Schreckenberger M, Zimny D, Wagenknecht G, Kaiser HJ, Dohmen BM, Bares R, Büll U.
    Nuklearmedizin; 1998 May 10; 37(3):83-9. PubMed ID: 9604227
    [Abstract] [Full Text] [Related]

  • 19. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
    Urbannek V, Voth E, Moka D, Schicha H.
    Nuklearmedizin; 2001 Aug 10; 40(4):111-5. PubMed ID: 11556200
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM, Lima N, Knobel M, Cavaliere H, Medeiros-Neto G.
    Eur J Med; 1993 Feb 10; 2(2):70-4. PubMed ID: 8258020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.